DiscoverInside Scope
Inside Scope
Claim Ownership

Inside Scope

Author: American Gastroenterological Association (AGA)

Subscribed: 21Played: 125
Share

Description

Welcome to Inside Scope, the American Gastroenterological Association podcast that will help you advance your patient care, one half-hour segment at a time. Join us to hear from the experts, learn new skills, and stay abreast of changing best practices in gastroenterology patient care.
74 Episodes
Reverse
Welcome to the rebroadcast six-episode series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging treatment options, and discuss best practices for transitions of care. In this episode, Drs. Paul Feuerstadt and Sahil Khanna are joined by guests Rebecca Perez and Cheri Lattimer to discuss case management and transitions of care in C. difficile infection. This episode was originally released in September 2023.This rebroadcast episode does not offer Continuing Medical Education (CME) credits. This original series was supported by educational grants from Aimmune Therapeutics, Inc., Seres Therapeutics, and Ferring Pharmaceuticals, Inc. This rebroadcast is supported solely by educational grant from Aimmune Therapeutics, Inc.
Welcome to the rebroadcast six-episode series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging treatment options, and discuss best practices for transitions of care. In this episode, Drs. Paul Feuerstadt and Sahil Khanna describe the shifts in the microbiota with C. difficile infection. This episode was originally released as a bonus episode in November 2022. This rebroadcast episode does not offer Continuing Medical Education (CME) credits. This original series was supported by educational grants from Aimmune Therapeutics, Inc., Seres Therapeutics, and Ferring Pharmaceuticals, Inc. This rebroadcast is supported solely by educational grant from Aimmune Therapeutics, Inc.
Welcome to the rebroadcast six-episode series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging treatment options, and discuss best practices for transitions of care. In this episode, Drs. Paul Feuerstadt and Sahil Khanna cover risk factors for initial and recurrent C. difficile infection. This episode was originally released as a bonus episode in November 2022. This rebroadcast episode does not offer Continuing Medical Education (CME) credits. This original series was supported by educational grants from Aimmune Therapeutics, Inc., Seres Therapeutics, and Ferring Pharmaceuticals, Inc. This rebroadcast is supported solely by educational grant from Aimmune Therapeutics, Inc.
Welcome to the rebroadcast six-episode series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging treatment options, and discuss best practices for transitions of care. In this episode, Drs. Paul Feuerstadt and Sahil Khanna are joined by guest Dr. Colleen Kelly to discuss how to reconcile guideline differences for testing and treatment of C. difficile. This episode was originally released in September 2023.This rebroadcast episode does not offer Continuing Medical Education (CME) credits. This original series was supported by educational grants from Aimmune Therapeutics, Inc., Seres Therapeutics, and Ferring Pharmaceuticals, Inc. This rebroadcast is supported solely by educational grant from Aimmune Therapeutics, Inc.
Welcome to the rebroadcast six-episode series: C. difficile: Preparing the Field for Change.This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging treatment options, and discuss best practices for transitions of care. In this episode, Drs. Paul Feuerstadt and Sahil Khanna are joined by guest Dr. Jessica Allegretti to discuss FMT and new microbiome therapies. This episode was originally released in September 2023.This rebroadcast episode does not offer Continuing Medical Education (CME) credits. This original series was supported by educational grants from Aimmune Therapeutics, Inc., Seres Therapeutics, and Ferring Pharmaceuticals, Inc. This rebroadcast is supported solely by educational grant from Aimmune Therapeutics, Inc.
loading
Comments